Product Overview
RadiaDyne's Oncology Tools
HaA Product Development collaborated with RadiaDyne to create advanced oncology tools designed to enhance the treatment of prostate cancer.
Problem:
Radiation oncologists face significant challenges in protecting critical organs and monitoring doses in real-time during treatment. These challenges necessitated an innovative solution to improve patient outcomes while reducing procedure time and costs.
Solution:
Starting from a conceptual "napkin sketch," HaA Product Development assisted RadiaDyne in developing their intellectual property into advanced radiation oncology tools. These tools offer virtual real-time in-vivo dose monitoring, significantly improving the stability and safety of therapy. This pioneering innovation not only enhanced the quality of care but also facilitated the acquisition of RadiaDyne by AngioDynamics for $150 million.
With RadiaDyne's cutting-edge oncology tools, HaA Product Development has advanced the efficiency and effectiveness of prostate cancer treatments, marking a significant milestone in medical technology.
Help others choose confidently by sharing your feedback.
